XML 62 R52.htm IDEA: XBRL DOCUMENT
v3.25.1

Royalty and Commercial Payment Purchase Agreements - Fully Recovered - Viracta (Details) $ in Thousands | 1 Months Ended | 3 Months Ended |
--- | --- | --- | ---
Mar. 31, 2021 USD ($) item | Mar. 31, 2025 USD ($) | Mar. 31, 2024 USD ($) | Dec. 31, 2024 USD ($)
Agreements |  |  |  |
Payments of consideration under RPAs, AAAs and CPPAs |  | $ 8,000 | $ 15,000 |
Long-term royalty and commercial payment receivables under the cost recovery method |  | 59,916 |  | $ 55,936
Acquisition of royalty and commercial payment receivables |  | 4,395 |  |
Reduction in long-term royalty receivable balance due to receipt of payment |  | 415 |  |
Trade and other receivables, net |  | 5,544 |  | 1,839
Income from purchased receivables under cost recovery method |  | 5,525 |  |
Viracta | OJEMDA |  |  |  |
Agreements |  |  |  |
Income from purchased receivables under cost recovery method |  | 5,525 |  |
Viracta | Royalty Purchase Agreement |  |  |  |
Agreements |  |  |  |
Number of drug candidates | item | 2 |  |  |
Payments of consideration under RPAs, AAAs and CPPAs | $ 13,500 |  |  |
Maximum amount of potential milestones, potential royalties on sales and other payments receivable | 54,000 |  |  |
Amount of maximum consideration retained | 5,000 |  |  |
Maximum amount of potential regulatory and commercial milestones receivable | 57,000 |  |  |
Long-term royalty and commercial payment receivables under the cost recovery method | $ 13,500 |  |  |
Trade and other receivables, net |  | 1,500 |  | $ 1,300
Income from purchased receivables under cost recovery method |  | 5,500 | $ 0 |
Income from purchased receivables under cost recovery method, Milestones |  | 4,000 |  |
Income from purchased receivables under cost recovery method, Royalties |  | $ 1,500 |  |

X
- Definition Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer. + References No definition available. + Details
Name: | us-gaap_AccountsAndOtherReceivablesNetCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of drug candidates under the terms of the agreement. + References No definition available. + Details
Name: | xoma_AgreementDrugCandidatesNumber
Namespace Prefix: | xoma_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of income that is not accounted for under Topic 606, in accordance with the cost recovery method. + References No definition available. + Details
Name: | xoma_IncomeNotFromContractWithCustomerCostRecoveryMethod
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of income that is not accounted for under Topic 606, in accordance with the cost recovery method related to milestone. + References No definition available. + Details
Name: | xoma_IncomeNotFromContractWithCustomerCostRecoveryMethodMilestone
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of income that is not accounted for under Topic 606, in accordance with the cost recovery method related to royalties. + References No definition available. + Details
Name: | xoma_IncomeNotFromContractWithCustomerCostRecoveryMethodRoyalties
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of maximum consideration retained by Company excluded from maximum potential milestones under terms of agreement. + References No definition available. + Details
Name: | xoma_MaximumConsiderationRetained
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Maximum amount of potential milestones, potential royalties on sales, and other payments, excluding consideration retained by company under the terms of the agreement. Excludes regulatory and commercial milestones. + References No definition available. + Details
Name: | xoma_MilestonesReceivableExcludingConsiderationRetainedMaximum
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of cash outflow for consideration under agreements, including Royalty Purchase Agreements (RPAs), Assignment and Assumption Agreements (AAAs), Commercial payment purchase agreement (CPPAs) and other agreements classified as investing activities. Payments may include upfront payments, one-time payments, milestone payments and contingent consideration payments. + References No definition available. + Details
Name: | xoma_PaymentOfConsiderationUnderAgreementsInvestingActivities
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Maximum amount of potential regulatory and commercial milestones receivable under the terms of the agreement. + References No definition available. + Details
Name: | xoma_RegulatoryAndCommercialMilestonesReceivableMaximum
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Increase in rights receivable due to acquisition of royalty and commercial payment receivables under the cost recovery method. Includes both current and noncurrent rights receivable. + References No definition available. + Details
Name: | xoma_RightsReceivableCostRecoveryMethodAcquisitionOfPaymentReceivable
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Decrease in rights receivable due to receipt of royalty and commercial payments under the cost recovery method. Includes both current and noncurrent rights receivable. + References No definition available. + Details
Name: | xoma_RightsReceivableCostRecoveryMethodReceiptOfPayments
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Royalty and commercial payment receivables under cost recovery method probable and reasonably estimable to be received after one year or beyond the normal operating cycle, if longer. + References No definition available. + Details
Name: | xoma_RoyaltyAndCommercialPaymentReceivablesCostRecoveryMethodLongTerm
Namespace Prefix: | xoma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | srt_CounterpartyNameAxis=xoma_ViractaTherapeuticsInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=xoma_TovorafenibMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=xoma_RoyaltyPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |